Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
The Incidence of Breast and Other Cancers Among Female Flight Attendants Research Initiative CDC NCI A cohort study of approximately 10,000 Pan Am flight attendants to determine cancer incidence (primarily breast cancer) associated with cosmic radiation and circadian disruption from their work.
The MDEpiNet TMJ RoundTable Meeting/ Workshop AHRQ, FDA NIDCR This workshop facilitated collaboration of stakeholders to address data on implant performance, surgical outcomes, and adverse events in an effort to: develop outcome and assessment and reporting tools based on patient input, the intersection of patient biology, anatomy, genetics, physiology with TMJ medical devices, and clinical patient-centered outcomes to better target therapies.
The Nanoscale Science, Engineering, and Technology (NSET) Subcommittee Committee, Work group, Advisory group, or Task Force CDC, FDA, ATSDR NCI, OD/OSP This subcommittee of the National Science and Technology Council's Committee on Technology is responsible for coordinating the National Nanotechnology Initiative (NNI). The NNI was established in 2001 to coordinate federal research and development in nanotechnology by providing a vision of the long-term benefits and opportunities offered by nanotechnology and acting as a locus for communication, cooperation, and collaboration between federal agencies involved in nanotechnology research and development. In 2016, the NSET updated its strategic plan to reflect the fact that nanotechnology is now a broadly enabling technology, not simply an area of research at the nanoscale. The new strategic plan outlines four goals: (1) advance a world-class nanotechnology research and development program, (2) foster the transfer of new technologies into products for commercial and public benefit, (3) develop and sustain educational resources, a skilled workforce, and a dynamic infrastructure and toolset to advance nanotechnology, and (4) support responsible development of nanotechnology.
The National Ending the HIV Epidemic (EHE) Meeting Meeting/ Workshop CDC, HRSA, OASH NIAID, NICHD, NIDA, NIMH, OD/DPCPSI/OAR On April 14-15, 2021, more than 300 academic investigators, government scientists, local health department professionals, and community members from throughout the U.S. participated in the virtual National Ending the HIV Epidemic (EHE) Meeting hosted by the NIH and the;DC CFAR. The meeting featured presentations by academic investigators and their implementation and community partners funded through NIH EHE awards and highlighted their data and experiences to date.
The Networking and Information Technology Research and Development (NITRD) Program Committee, Work group, Advisory group, or Task Force AHRQ, ONC, CDC OD/DPCPSI/ODSS, NLM, NHGRI, NIBIB, NCI, NCATS NITRD coordinates Federal R;D to identify, develop, and transition into use the secure, advanced IT, high-performance computing, networking, and software capabilities needed by the Nation, and to foster public-private partnerships that provide world-leading IT capabilities.;As a NSTC subcommittee, the President’s Council of Advisors for Science and Technology (PCAST) provides regular reviews of the NITRD programs.
The NIH Helping to End Addiction Long Term (HEAL) Initiative Research Initiative AHRQ, CDC, CMS, HRSA, OS, SAMHSA NIDA, NCATS, NCCIH, NHLBI, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDDK, NIMH, NINDS, OD/OSP In April 2018, the National Institutes of Health (NIH) launched the HEAL (Helping to End Addiction Long-term) Initiative, an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. This Initiative will build on extensive, well-established NIH research, including basic science of the complex neurological pathways involved in pain and addiction, implementation science to develop and test treatment models, and research to integrate behavioral interventions with medications for opioid use disorder (OUD) The NIH HEAL Initiative will bolster research across NIH to improve treatments for opioid misuse and addiction and enhance pain management.
The Nutiriton Research Coordinating Committee (NRCC) Committee, Work group, Advisory group, or Task Force ACL, AHRQ, ASPE, CDC, FDA, HRSA, OASH OD/DPCPSI/ONR The Nutrition Research Coordinating Committee (NRCC) was established by the National Institutes of Health (NIH) Office of the Director in 1975 to improve communication and research coordination of nutrition activities within the NIH and across the federal government. Today it provides an open forum for members to discuss current and future nutrition research challenges and opportunities. The NRCC has broad representation from the NIH institutes and centers. In addition, liaisons from other federal offices and agencies also participate. The NRCC meets monthly, alternating between intra-NIH and interagency meetings. NRCC membership is open to any federal staff member interested in carrying out any trans-NIH or trans-agency nutrition research efforts.
The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) Research Initiative CDC NIAID The PREVAIL partnership was established between the governments of Liberia and the United States. The Government of Liberia is represented through the Ministry of Health (MOH) and three autonomous agencies, the United States government is represented through NIAID and the Centers for Disease Control (CDC). The purpose of this partnership is to conduct collaborative biomedical and public health research ;to advance science, strengthen health policy and practice, and improve the health of Liberians and people worldwide while enhancing Liberian preparedness and agility to rapidly respond during any future infectious disease outbreaks.
The President's Task Force on Environmental Health risks and Safety risks to children; Asthma Disparities working group Committee, Work group, Advisory group, or Task Force AHRQ, CDC, CMS, FDA, IHS NHLBI, NIAID, NICHD, NIMHD, NINR Group of federal partners (HHS and non-HHS) working to eliminate disparities in children with asthma
The Scientific Registry of Transplant Recipients (SRTR) Visiting Committee Committee, Work group, Advisory group, or Task Force HRSA NIAID The SRTR Visiting Committee advises the SRTR on:(1) analytic methodologies to support the Organ Procurement and Transplantation Network policy development and evaluation; (2) objectives, study designs, and statistical methods for research projects performed by SRTR, including risk-adjusted analyses of organ procurement organization and transplant program performance; (3) methods used in simulated allocation models; (4) new areas of research and innovative advances in analytical methodologies that might improve the effectiveness of SRTR.